Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Harlan W. Waksal
AddedFeb 19, 2024
UpdatedMay 31, 2026
Harlan W. Waksal

Harlan W. Waksal

Board Member, Roadmap Capital

CrunchbaseLinkedInThe Org

Harlan W. Waksal's Career

Roadmap Capital
Roadmap Capital

Toronto, Ontario, CA

Board Member· Board
Lyra Therapeutics
Lyra Therapeutics

Watertown, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Harlan W. Waksal's Career

Roadmap Capital
Roadmap Capital
Investment FirmInvestment Firm92013Toronto, Ontario, CA
Board Member· Board

Leadership at Roadmap Capital

Hugh ClelandHugh ClelandCo-Founder
Riadh ZineRiadh ZineCo-Founder

Similar to Roadmap Capital

Autumn Road CapitalAutumn Road CapitalWestport, CT, USest. 2022Autumn Road CapitalWestport, CT, US · est. 2022

Westport-based Autumn Road Capital leverages diverse investment expertise to accelerate portfolio company growth.

Investment Firm2
Beyond CapitalBeyond CapitalLondon, Greater London, GBest. 2021Beyond CapitalLondon, Greater London, GB · est. 2021

Pre-Seed to Series A investment platform connecting companies with LPs & Founders.

Investment Firm3
Leadout CapitalLeadout CapitalPortola Valley, CA, USest. 2018Leadout CapitalPortola Valley, CA, US · est. 2018

Leadout Capital: An early-stage venture capital fund backing resilient founders in underserved markets.

Investment Firm9
468 Capital468 CapitalBerlin, Berlin, DEest. 2020468 CapitalBerlin, Berlin, DE · est. 2020

468 Capital: A global technology investment firm, empowering entrepreneurs to define business categories since 2020.

Investment Firm24
Lyra Therapeutics
Lyra Therapeutics
Public$264.1M662014Watertown, MA, US
Board Member· Board

Leadership at Lyra Therapeutics

George WhitesidesGeorge WhitesidesCo-Founder
Nancy SnydermanNancy SnydermanBoard Member
Paulina HillPaulina HillBoard Member
Bob LangerBob LangerBoard Member
Guido NeelsGuido NeelsBoard Member
Konstantin PoukalovKonstantin PoukalovBoard Member

Similar to Lyra Therapeutics

LyndraLyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161

Harlan W. Waksal's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailSeong-Sook HanSeong-Sook HanBoard Member · NaverDae Gyu ByunDae Gyu ByunBoard Member · NaverCheong Ui-JongCheong Ui-JongBoard Member · Naver

People Similar to Harlan W. Waksal

Jon OliverJon OliverBoard Member · Rutgers UniversityPhil NechesPhil NechesBoard Member · CaltechZeev HoltzmanZeev HoltzmanChairman at Israel Venture Research CenterSylvia MaierSylvia MaierBoard Member · New York UniversityJean HoffmanJean HoffmanBoard Member · MedRhythmsLiat AaronsonLiat AaronsonBoard Member · Cockpit Innovation